ロード中...
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) has become the most frequently encountered chronic liver disease. NAFLD is associated with increased liver-related morbidity and mortality, but also contributes to cardiovascular disease, diabetes and non-liver-related malignancy. Non-alcoholic steatohepatit...
保存先:
| 出版年: | Adv Ther |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6824365/ https://ncbi.nlm.nih.gov/pubmed/30888594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-019-00898-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|